Immediate cerebral symptoms during rapid intravenous administration of cyclophosphamide (NSC-26271).
D000328:Adult; D000368:Aged; D001921:Brain / Q000187:drug effects*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
D003520:Cyclophosphamide